The role of skeletal tissue remodeling markers in the patho-genesis of implant-associated inflammation after primary knee arthroplasty
Year: 2018, volume 14 Issue: №3 Pages: 515-518
Heading: Traumatology and Orthopedics Article type: Original article
Authors: Galashina Е.А., Bondarenko A.S., Ulyanov V.Yu., Klimov S.S.
Organization: Saratov State Medical University
Heading: Traumatology and Orthopedics Article type: Original article
Authors: Galashina Е.А., Bondarenko A.S., Ulyanov V.Yu., Klimov S.S.
Organization: Saratov State Medical University
Summary:
Aim: to reveal certain mechanisms of the pathogenesis of implant-associated inflammation by the level of resorption and bone tissue genesis markers in patients who underwent primary knee arthroplasty. Material and Methods. Main group consisted of 40 patients with implant-associated inflammation; first comparison group — of 20 patients with primary aseptic loosening of knee joint implant components; second comparison group — of 20 patients who underwent primary knee arthroplasty without complications in post-operative period; control group — of 20 conventionally healthy individuals. The levels of soluble receptor activator of nuclear factor kappa-B ligand and bone morphogenetic protein-2were defined in blood serum of all subjects by ELISA. Results. In patients of main group we observed more pronounced increase of soluble receptor activator of nuclear factor kappa-B ligand content and significant decrease of bone morphogenetic protein-2 content in blood serum; patients of first comparison group demonstrated activation of soluble receptor activator of nuclear factor kappa-B ligand and decreased levels of bone morphogenetic protein-2 in blood serum; patients of second comparison group did not demonstrate any changes in the studied indexes. Conclusion. The activation of soluble receptor activator of nuclear factor kappa-B ligand and decreased activity of bone morphogenetic protein-2 have leading role in the pathogenesis of implant-associated inflammation.
Keywords: primary arthroplasty, pathogenesis, metabolic markers, implant-associated inflammation, bone
Bibliography:
1 Filippenko VA, Marushchak AP, Tankut AV, et al. Periprosthetic infection: diagnosis and treatment; Part 2
(literature review). Orthopedics, Traumatology and Prosthetics 2016; 3 (604): 104-9
2 Klyushin NM, Ermakov AM, Ababkov YuV, et al. The importance of clinical and radiological evaluation in the
diagnosis and treatment of periprosthetic joint infection following hip arthroplasty. Genij Ortopedii 2017; 23 (3): 341-5
3 Prokhorenko VM, Pavlov VV, Petrova NV. The prophylaxis, diagnostics and treatment of the early infection of
surgical intervention area in hip replacement. Traumatology and orthopedics of Russia 2008; 2 (48): 84-90
4 Smirnov AV, Rumyantsev ASh. Bone tissue function and structure under normal and pathological condition:
Message II. Nephrology 2015; 19 (1): 8-17
5 Semenov PS. Use of bone morphogenetic protein-2 for osseoregeneration stimulation. Science Journal of
Volgograd State University. Young researchers' work 2013; (11): 81-3
6 Rozhnova ОМ, Prokhorenko VM, Sadovoy MA, et al. Pathogenetic factors of aseptic loosening of joint implants
(review). The Siberian Scientific Medical Journal 2015; 35 (5): 84-9
7 Sagalovski S, Shenert М. Cellular and molecular mechanisms of development of aseptic instability of hip implant.
Trauma 2012; 13 (1): 153-60
8 Dmitrieva LA, Lebedev VF, Korshunova EYu. Complications at the hip replacement and ways of their prediction
(review of literature). Bulletin of the SSC of the Russian Academy of Medical Sciences 2013; 90 (2): 153-8
9 Tsumaki N, Nakase Т, Miyaji Т, et al. Bone morphogenetic protein signals are required for cartilage formation and
differently regulate joint development during skeletogenesis. J Bone Miner Res 2002; 17: 1575-82
10 Petrova NV. Evidence-based diagnosis of implant-associated infection in orthopedic surgery. Spine Surgery
2012; (1): 74-83.
| Attachment | Size |
|---|---|
| 2018_3-1_515-518.pdf | 257.51 KB |
Русский
English